Patient-Friendly Explanation

GIP is a hormone released from the gut after eating that helps the body handle sugar and store fat. Along with GLP-1, it is one of the incretin hormones that control appetite and blood sugar. Newer weight loss medications work by targeting both GIP and GLP-1 receptors together.

Clinical Definition

Gastric inhibitory polypeptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is an incretin secreted by duodenal and jejunal K-cells in response to nutrient ingestion. It potentiates glucose-stimulated insulin secretion, promotes lipid uptake and fat storage in adipose tissue, and may modulate central appetite pathways. Dual GIP/GLP-1 receptor agonists such as tirzepatide exploit this pathway for weight reduction.

Why It Matters

Understanding how GIP works helps patients make sense of how dual-action weight loss medications function, a key topic in medication reviews at NuLifeCare Singapore.